Magstim Awarded FDA (510K) Clearance for Advanced Transcranial Magnetic Stimulation (TMS) Platform Horizon 3.0

New Class of Navigated TMS Delivers Customized, Repeatable Treatments Improving Patient Care and Clinical Efficiencies Magstim, the global leader in neuroscience research and treatment for mental

Related Keywords

Florida ,United States ,Telegraph Hill ,California ,San Francisco ,Kostenloser Wertpapierhandel ,Mark Sejvar ,Magstim Stimguide ,Lothar Krinke ,Khaled Bowarshi ,New Class ,Repeatable Treatments Improving Patient Care ,Clinical Efficiencies ,Magstim Connect ,Magstim Stimulators ,Business Wire ,Magstim Magnetic Stimulation ,Technomed Clinical Neurophysiology ,Neurosign Interoperative Nerve ,Telegraph Hill Partners ,Magstim ,Warded ,10k ,Clearance ,Dvanced ,Transcranial ,Agnetic ,Stimulation ,Platform ,Horizon ,